Patient knowledge and use of acetaminophen in over-the-counter medications

Journal of the American Pharmacists Association

Volumn 54, Issue 1, 2014, Pages 19-26

  Hurwitz, Jason ^a   Sands, Shannon ^a,b   Davis, Erica ^a,c   Nielsen, Joel ^a,d   Warholak, Terri ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b CVS Caremark   (United States)

^c KINGSBROOK JEWISH MEDICAL CENTER   (United States)

^d Tempe St Luke's Hospital   (United States)

Author keywords

Acetaminophen; Administration; Dosage; Nonprescription drugs; Packaging; Safety

Indexed keywords

ACETYLSALICYLIC ACID; BISMUTH SALICYLATE; DOXYLAMINE; EXCEDRIN; GUAIFENESIN; IBUPROFEN; NAPROXEN; NON PRESCRIPTION DRUG; NYQUIL COLD AND FLU; PARACETAMOL; PSEUDOEPHEDRINE; TYLENOL EXTRA STRENGTH; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEATH; DRUG CAPSULE; DRUG FORMULATION; DRUG INTOXICATION; DRUG OVERDOSE; DRUG PACKAGING; DRUG SAFETY; DRUG USE; EDUCATION; FEMALE; HUMAN; LIVER INJURY; MALE; MEASUREMENT ACCURACY; MIDDLE AGED; NORMAL HUMAN; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT SAFETY; PHARMACY; SEMI STRUCTURED INTERVIEW; SEX DIFFERENCE; SUSPENSION; VERY ELDERLY; YOUNG ADULT;

ACETAMINOPHEN; ADULT; AGED; AGED, 80 AND OVER; COMPREHENSION; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; RISK; YOUNG ADULT;

EID: 84892776065     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2014.13077     Document Type: Article

References (45)

1. Albertson TE, Walker V Jr, Stebbins MR, et al. A population study of the frequency of high-dose acetaminophen prescribing and dispensing. Ann Pharmacother. 2010;44(7-8):1191-5.
2. Lee WM. Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology. 2004;40(1):6-9.
3. Food and Drug Administration. FDA requires additional labeling for over-the-counter pain relievers and fever reducers to help consumers use products safely. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2009/ ucm149573.htm. Accessed September 6, 2012.
4. Hornsby LB, Przybylowicz J, Andrus M, Starr J. Survey of physician knowledge and counseling practices regarding acetaminophen. J Patient Saf. 2010;6(4):216-20.
5. Lee WM. The case for limiting acetaminophen-related deaths: smaller doses and unbundling the opioid-acetaminophen compounds. Clin Pharmacol Ther. 2010;88(3):289-92.
6. McNeil-PPC. Understanding acetaminophen. www.tylenolprofessional.com/ assets/v4/understanding-acet-2p.pdf. Accessed September 6, 2012.
7. Cohen H. Helping patients and families avoid inadvertent acetaminophen overdose. J Emerg Nurs. 2007;33(3):249-51.
8. Simon HK, Weinkle DA. Over-the-counter medications: do parents give what they intend to give? Arch Pediatr Adolesc Med. 1997;151(7):654-6.
9. Food and Drug Administration. Recommendations for FDA interventions to decrease the occurrence of acetaminophen hepatotoxicity. www.fda.gov/ohrms/ dockets/ac/09/briefing/2009-4429b1-02-FDA.pdf. Accessed September 3, 2012.
10. Food and Drug Administration. Questions and answers on final rule for labeling changes to over-the-counter pain relievers. www.fda.gov/Drugs/ NewsEvents/ucm144068.htm. Accessed September 6, 2012.
11. Consumer Healthcare Products Association. OTC industry announces voluntary transition to one concentration of single-ingredient pediatric liquid acetaminophen medicines. http://chpa-info.org/05-04-11-Ped-Acet.aspx. Accessed September 6, 2012.
12. Gever J. No more infant dose of OTC acetaminophen. www.medpagetoday.com/ Pediatrics/GeneralPediatrics/26297. Accessed September 6, 2012.
13. American Educational Research Association, American Psychological Association, National Council on Measurement in Education (Eds.). Validity. In: Standards for educational and psychological testing. Washington, DC: American Educational Research Association; 1999:9-24.
14. Cronbach LJ, Meehl PE. Construct validity in psychological tests. Psychol Bull. 1955;52(4):281-302.
15. Downing SM. Threats to the validity of locally developed multiple-choice tests in medical education: construct-irrelevant variance and construct underrepresentation. Adv Health Sci Educ Theory Pract. 2002;7(3):235-41.
16. Messick S. Validity. In: Linn RL. Ed. Educational measurement. 3rd ed. New York: MacMillan; 1989:13-103.
17. Messick S. The interplay of evidence and consequences in the validation of performance assessments. Educational Researcher. 1994;23(2):13-23.
18. Nunnally JC, Bernstein IH (Eds.). Validity. In: Psychometric theory. New York: McGraw-Hill,; 1994.
19. Draugalis JR, Jackson TR. Objective curricular evaluation: applying the Rasch model to a cumulative examination. Am J Pharm Educ. 2004;68(2):35.
20. Colliver JA, Williams RG. Technical issues: test application: AAMC. Acad Med. 1993;68(6):454-60.
21. Smith EV Jr. Evidence for the reliability of measures and validity of measure interpretation: a Rasch measurement perspective. J Appl Meas. 2001;2(3):281-311.
22. Jackson TR, Draugalis JR, Slack MK, et al. Validation of authentic performance assessment: a process suited for Rasch modeling. Am J Pharm Educ. 2002;66(3):233-42.
23. Briggs AL, Jackson TR, Bruce S, Shapiro NL. The development and performance validation of a tool to assess patient anticoagulation knowledge. Res Social Adm Pharm. 2005;1(1):40-59.
24. Rasch G. Probabilistic models for some intelligence and attainment tests. Copenhagen, Denmark: Danish Institute for Educational Research; 1960.
25. Wright BD, Stone MH. Best test design: Rasch measurement. Chicago: Mesa; 1979:1-24.
26. Wright B, Panchapakesan N. A procedure for sample-free item analysis. Educ Psychol Meas. 1969;29(1):23-48.
27. Hambleton RK, Swaminathan H, Rogers HJ. Test construction: fundamentals of item response theory. 1st ed. Newbury Park, CA: Sage; 1991:99-107.
28. Liao PM, Campbell SK. Examination of the item structure of the Alberta infant motor scale. Pediatr Phys Ther. 2004;16(1):31-8.
29. Pesudovs K, Garamendi E, Keeves JP, Elliott DB. The Activities of Daily Vision Scale for cataract surgery outcomes: re-evaluating validity with Rasch analysis. Invest Ophthalmol Vis Sci. 2003;44(7):2892-9.
30. Duncan PW, Bode RK, Min Lai S, et al. Rasch analysis of a new stroke-specific outcome scale: the Stroke Impact Scale. Arch Phys Med Rehabil. 2003;84(7):950-63.
31. O'Connor RJ, Cano SJ, Thompson AJ, Hobart JC. Exploring rating scale responsiveness: does the total score reflect the sum of its parts? Neurology. 2004;62(10):1842-4.
32. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4(4):293-307.
33. Lai SM, Perera S, Duncan PW, Bode R. Physical and social functioning after stroke: comparison of the Stroke Impact Scale and Short Form-36. Stroke. 2003;34(2):488-93.
34. Gold Standard, Inc. Acetaminophen. http://clinicalpharmacology-ip.com/ Forms/Monograph/monograph.aspx?cpnum=4&sec=monindi&t=0. Accessed April 8, 2013.
35. Wright B, Linacre J. Reasonable mean-square fit values. www.rasch.org/rmt/rmt83b.htm. Accessed September 6, 2012.
36. Wright BD, Stone MH. Judging misfit: making measures. Chicago: Phaneron; 2004:19-33.
37. Wright B. Diagnosing misfit: Rasch measurement transactions. 1991:5(2):156.
38. Smith RM. Item analysis in the Rasch model: IPARM: item and person analysis with the Rasch model. Chicago: Mesa; 1991:164-81.
39. Linacre JM, Wright BD. Interpreting output tables: a user's guide to BIGSTEPS WINSTEPS Rasch model computer program. Chicago: Mesa; 2001:94-115.
40. National Council for Prescription Drug Programs. NCPDP recommendations for improved prescription container labels for medicines containing acetaminophen. www.fda.gov/downloads/Drugs/DrugSafety/UCM266631.pdf. Accessed August 19, 2012.
41. Fritsch B. FDA's safe use initiative: reducing harm risk from acetaminophen. Pharmacy Today. 2010;16(9):61.
42. Stumpf JL, Skyles AJ, Alaniz C, et al. Knowledge of appropriate acetaminophen doses and potential toxicities in an adult clinic population. J Am Pharm Assoc. 2007;47(1):35-41.
43. King JP, Davis TC, Bailey SC, et al. Developing consumer-centered, nonprescription drug labeling: a study in acetaminophen. Am J Prev Med. 2011;40(6):593-8.
44. Chen L, Schneider S, Wax P. Knowledge about acetaminophen toxicity among emergency department visitors. Vet Hum Toxicol. 2002;44(6):370-3.
45. Hornsby LB, Whitley HP, Hester EK, et al. Survey of patient knowledge related to acetaminophen recognition, dosing, and toxicity. J Am Pharm Assoc. 2010;50(4):485-9.